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ABSTRACT 9 
BACKGROUND: 3-dimensional imaging modalities for optically dense connective tissues 10 
such as tendons are limited and typically have a single imaging methodological endpoint. Here, 11 
we have developed a bimodal procedure utilising fluorescence-based confocal microscopy and 12 
x-ray micro-computed tomography for the imaging of adult tendons to visualise and analyse 13 
extracellular sub-structure and cellular composition in small and large animal species.  14 
RESULTS: Using fluorescent immunolabelling and optical clearing, we visualised the 15 
expression of the novel cross-species marker of tendon basement membrane, laminin-α4 in 3D 16 
throughout whole rat Achilles tendons and equine superficial digital flexor tendon 5 mm 17 
segments. This revealed a complex network of laminin-α4 within the tendon core that 18 
predominantly localises to the interfascicular matrix compartment. Furthermore, we 19 
implemented a chemical drying process capable of creating contrast densities enabling 20 
visualisation and quantification of both fascicular and interfascicular matrix volume and 21 
thickness by x-ray micro-computed tomography. We also demonstrated that both modalities 22 
can be combined using reverse clarification of fluorescently labelled tissues prior to chemical 23 
drying to enable bimodal imaging of a single sample. 24 
CONCLUSIONS: Whole-mount imaging of tendon allowed us to identify the presence of an 25 
extensive network of laminin-α4 within tendon, the complexity of which cannot be appreciated 26 
using traditional 2D imaging techniques. Creating contrast for x-ray micro-computed 27 
tomography imaging of tendon using chemical drying is not only simple and rapid, but also 28 
markedly improves on previously published methods. Combining these methods provides the 29 
ability to gain spatio-temporal information and quantify tendon substructures to elucidate the 30 
relationship between morphology and function. 31 
KEYWORDS: tendon, interfascicular matrix, optical clarification, confocal microscopy, x-ray 32 
micro-computed tomography, LAMA4  33 
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INTRODUCTION 34 
Advances in 3-dimensional (3D) imaging of dense connective tissues such as tendons are 35 
essential for the investigation of normal tissue structure as well as musculoskeletal diseases in 36 
pre-clinical models and clinical samples. Recent developments in 3D microscopy and scanning 37 
techniques have permitted imaging of cells and structures of calcified tissues, whole embryos, 38 
and organisms, using methods including phase-contrast x-ray micro-computed tomography (μ-39 
CT), optical projection tomography and label-free detection methods (1–3). However, 3D 40 
imaging by fluorescent methods remains a challenge for adult tissues such as cartilage, 41 
ligaments and tendons, as their opacity and dense matrix composition renders deep imaging of 42 
whole connective tissues difficult. Paradoxically, μ-CT of non-calcified tissues is technically 43 
difficult due to their lower x-ray attenuation compared to mineralised tissues such as bone (4). 44 
Hence, there is a demand for imaging modalities that can be used to study the gross structure 45 
of connective tissues as well as the spatial organisation of extracellular matrix (ECM) and its 46 
inter-relationships with resident cell populations.  47 
Until recently, imaging techniques to investigate both structural and cellular elements 48 
of dense collagenous tissues such as adult tendon have been limited to conventional 2D 49 
methods. These only allow appreciation of tissue structure in a single plane or require extensive 50 
reconstruction (5), and are time-consuming, labour-intensive, and destructive, often creating 51 
artefacts within tissue (6). Recent advances in optical clearing agents have provided scope to 52 
clarify tissues, either by dehydration, delipidation, matching tissue refractive index or a 53 
combination of each, to allow 3D visualisation of ECM organisation and cell populations in 54 
both mineralised and non-mineralised tissues (7–11). A plethora of clearing agents are now 55 
commercially available, with a number of studies describing their effectiveness for fluorescent 56 
imaging of connective tissues with varying degrees of success (12–15). In addition, reversing 57 
optical clarification of collagenous structures is possible with a variety of aqueous compounds, 58 
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such as rehydration by saline-based solutions of glycerol or benzyl benzoate based clearing 59 
agents (13,16). Visikol® HISTO™ is a clearing agent reversible by ethanol which has only 60 
minor effects on tissue structure (17), with recent studies able to reverse tissue clearing for 61 
histological imaging post-3D imaging (18,19). Therefore, the reversibility of clarification 62 
agents introduces a new potential to better integrate different imaging modalities to resolve 63 
tissue structure and cell-ECM relationships. Further, the ability to image the same sample using 64 
the distinct modalities described herein has the potential to reduce the number of animals 65 
required and therefore contribute to more humane animal research, according to the 3Rs 66 
principles which necessitate Replacement, Reduction and Refinement of animal usage (20).  67 
To the authors’ knowledge, no study to date has attempted to establish bimodal 68 
procedures to image fluorescently labelled soft tissues in 3D and apply a distinct modality, 69 
such as μ-CT, to assess gross structural parameters quantitatively. Hence, post-clarification 70 
imaging by μ-CT could provide a new avenue for soft tissue research to investigate structure-71 
function relationships in conjunction with 3D immunolabelling approaches. However, 72 
contrast-enhanced 3D imaging in soft tissues remains difficult due to current strategies being 73 
limited by long perfusion times and an inability to fully resolve tissue structure due to 74 
insufficient contrast. Recent studies have described procedures to image soft tissues such as 75 
tendon with μ-CT using common aqueous contrast agents for such as iodine potassium iodide 76 
(I2KI; also referred to as Lugol’s solution) and phosphotungstic acid (21). However, acidic 77 
agents such as phosphotungstic acid require high concentrations to create contrast which can 78 
erode samples and distort structure in soft tissues, whereas iodine-based agents require variable 79 
incubation times and may ultimately provide inadequate contrast to visualise and segment soft 80 
tissue sub-structures (21). Hence, alternatives such as chemical and critical point drying should 81 
be considered, given both methods have been shown to generate excellent contrast in soft 82 
tissues (22–26). Recent advances have exploited chemical drying by hexamethyldisilazane 83 
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(HMDS) to generate contrast for 3D visualisation of soft tissue internal structure, although this 84 
technique has yet to be applied to tendon (27,28). 85 
Combining imaging that reveals internal structure of connective tissues with markers 86 
of cell:ECM specialisation in a single sample is an attractive possibility. In tendons, a number 87 
of fibrous proteins, proteoglycans, and glycoproteins that comprise basement membranes have 88 
been shown to localise to the interfascicular matrix (IFM), which surrounds tendon fascicles 89 
(reviewed in (29)). Basement membranes are highly specialised ECMs that interact with cell 90 
surface receptors, and are integral to progenitor cell niches, governing fate determination, 91 
structural integrity in musculoskeletal tissues (reviewed in (30) and (31)). Laminin is an 92 
essential basement membrane glycoprotein that interacts with cell adhesion molecules and cell 93 
surface receptors to regulate various cellular and molecular processes (32,33). In tendon, 94 
laminin and other basement membrane-associated proteins have been described previously 95 
(34,35), with recent proteomic studies identifying numerous laminin subunits, including 96 
laminin α-4 (LAMA4), localised to the IFM (36). However, the 3D organisation and 97 
composition of basement membrane proteins within the tendon core has yet to be described. 98 
Therefore, we utilised a novel cross-species marker of tendon basement membrane, LAMA4, 99 
combined with optical clearing techniques, to visualise 3D organisation of structural 100 
components in tendon. 101 
Given the demand for 3D imaging modalities for dense connective tissues, we 102 
developed techniques for whole-mount confocal microscopy and x-ray micro-computed 103 
tomography to achieve 3D visualisation and analysis of adult tendons. Furthermore, we aimed 104 
to develop a method applicable to tissues from both small and large animal models, testing our 105 
method in a rat (Rattus norvegicus) and equine (Equus caballus) tendon. Next, we developed 106 
a workflow for bimodal single sample imaging, combining our confocal and μ-CT imaging 107 
methodologies to visualise cellular and structural properties of tendon in 3D. 108 
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RESULTS 109 
To develop a method that enables both fluorescent imaging of cell-ECM architecture 110 
and x-ray scanning of dense connective tissue structure, we combined multiple processes to 111 
create a workflow that integrates whole-mount immunolabelling, reversible optical 112 
clarification, and subsequent chemical drying to enable bimodal 3D imaging of tendon by 113 
confocal microscopy and μ-CT (Figure 1). We applied this technique to whole rat Achilles 114 
tendons and segments of equine superficial digital flexor tendons (SDFT). A more detailed 115 
schematic describing data analysis workflows for each independent method is provided in the 116 
supplementary information (Figure S1). 117 
Prior to 3D imaging, appropriate antibody concentrations were identified and 118 
expression of LAMA4 was confirmed in both rat Achilles and equine SDFT using traditional 119 
2D fluorescent immunolabelling of tendon sections (Figure S2). Thereafter, we performed 120 
tissue immunolabelling and optical clarification with Visikol HISTO™ solutions to visualise 121 
3D organisation of LAMA4 in whole rat Achilles and in segments of equine SDFT using 122 
confocal microscopy using optimised protocols based on size-specific guidelines provided by 123 
Visikol™. As tissue thickness was similar between both equine SDFT segments and rat 124 
Achilles tendon, initial immunolabelling steps, including washing, permeabilisation, detergent 125 
washes and blocking were performed for identical periods of times. The main difference 126 
between protocols were antibody concentrations, which differed based on initial optimisations 127 
using thin tissue sections. The entire protocol, including nuclei counterstaining and dehydration 128 
steps prior to optical clarification requires a minimum of 12 days with no stopping points. 129 
Based on our optimised protocol, clarification rendered both SDFT segments and whole 130 
rat Achilles transparent within 4.5 days. This was achieved with minimal clearing times (SDFT 131 
= 72 h; rat Achilles = 108 h) according to the manufacturer’s guidelines. Longer clearing times 132 
were selected for the rat Achilles as lower permeability was expected due to the presence of 133 
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the epi- and para-tenons on the tendon surface, which have been shown to act as a retentive 134 
barrier (34). If necessary, clarification steps can be extended without negatively affecting 135 
labelling or tissue integrity. Using 3D projections of image stacks acquired by confocal 136 
imaging, we were able to visualise widespread vessel-like organisation of the structures 137 
labelled positively for basement membrane protein LAMA4 within the rat Achilles and equine 138 
SDFT (Figure 2 & Figure 4); information that cannot be gained from traditional 2D imaging. 139 
In the rat Achilles, LAMA4 expression was localised to the tendon surface and structures with 140 
a distribution likely to comprise the IFM (Figure 2 & Figure 3). In equine SDFT segments 141 
taken from the tendon core, the majority of LAMA4 labelling was seemingly consistent with 142 
IFM with some LAMA4 deposition in fascicles (Figure 4). Our method achieved imaging 143 
depths of at least 200 microns in equine SDFT and throughout an entire rat Achilles tendon 144 
(approximately 800 microns). 145 
A key disadvantage to most commercially available optical clearing agents is the 146 
irreversibility of the clearing procedures. Here, we used an ethanol-based dehydration 147 
procedure for reverse clarification of Visikol HISTO™ solutions, followed by a previously 148 
described chemical drying process using HMDS to generate contrast for μ-CT (37). Using grey-149 
scale images captured from reconstructed μ-CT tomograms of reverse cleared and dried 150 
samples, we demonstrated that HMDS drying provides excellent contrast capable of visualising 151 
tendon surface and core structure in both species. Additionally, false colour 3D volume 152 
rendering provides indication of relative densities and enhances visualisation of tendon internal 153 
structure (Figure 5 & Figure 6). 154 
An important feature of these morphometric approaches is the scope they provide for 155 
detailed quantitative analysis of the tissue organisation. To demonstrate this utility, we 156 
therefore used an automated segmentation procedure to separate both IFM and fascicle 157 
structures in equine SDFT. By adapting pre-existing measurement modalities used for routine 158 
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3D bone analyses (38), designed for measurement of bone parameters (see Table 1), we were 159 
able to record tendon volume (TV), IFM volume relative to tendon volume (IV/TV), and IFM 160 
thickness (IFM.th) (Figure 7). To explore the possibility that such quantitative methods to 161 
assess tendon sub-structures may be impacted by artefacts introduced by optical clarification 162 
and reverse clearing, we scanned reverse cleared and non-cleared segments derived from the 163 
same tendon, that had both been HDMS-dried and compared IFM and tendon measurements. 164 
As expected, we found there was no difference in tendon volume as both samples (4.80-4.82 165 
mm3) were analysed using the same volume-of-interest (1.75 mm x 1.75 x 2 mm). We found 166 
that reverse clarification had no obvious effect on tendon structure or IFM, as IFM volume did 167 
not differ markedly between the HMDS only (0.26 mm3) and reverse cleared, HMDS-dried 168 
tendon samples (0.31 mm3). With no stark difference between IFM volume observed, there 169 
were consequent similarities in IFM volume to tendon volume (IV/TV), with the HMDS-dried 170 
segment (5.5%) exhibiting similar relative IFM volume to the reverse cleared tendon (6.3%) 171 
segment. Furthermore, IFM thickness measurements also confirmed that reverse clarification 172 
had no adverse effect on tendon sub-structure analyses, with reverse cleared tendon exhibiting 173 
a similar IFM thickness (0.022 mm) compared to the IFM measured in the HMDS-dried 174 
segment (0.019 mm). Moreover, both conditions exhibited IFM thicknesses that fall within the 175 
range of previously reported IFM thickness measurements (0.01-0.025 mm) for an individual 176 
equine SDFT using 3D histological reconstructions (39). Hence, reversible clarification 177 
procedures appear to have no discernible effect on tendon sub-structure. 178 
DISCUSSION 179 
We present a technique combining whole-mount confocal microscopy and μ-CT for the 180 
imaging of adult tendon, using a reversible clearing approach that renders tissue transparent for 181 
confocal imaging, followed by reverse clarification and chemical drying that permits contrast-182 
enhanced μ-CT. We have demonstrated that not only does our methodology provide 183 
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independent fluorescence and x-ray-based imaging modalities for dense connective tissues in 184 
the adult, but also enables both modalities to be combined for bimodal imaging of a single 185 
sample. This approach overcomes the limitations of traditional disruptive serial sectioning and 186 
en bloc staining procedures, introducing methods for visualising tissue structure within a single 187 
sample at a meso- and microscopic scale to elucidate the relationship between cell and ECM 188 
in the context of tissue structure and function.  189 
We applied our bimodal procedure to both rat and equine tendons to demonstrate that 190 
our method can be applied to small and large animal models. Hence, bimodal imaging offers 191 
the potential to image tendon structures for comparative biology purposes as well as for 192 
pathological conditions. Here, we used a novel marker of tendon basement membrane, 193 
LAMA4, to visualise equine and rat tendon sub-structure. LAMA4 is a component of laminin-194 
8, laminin-9, and laminin-14, and has been described as a key regulator of basement membrane 195 
remodelling and function in adipose, cardiac, endothelial, hematopoietic, muscular, neuronal, 196 
and renal cell niches (40–43). Our 3D imaging modality identified a complex network of 197 
LAMA4 immunolabelling in the core of tendons from both small and large animals, where it 198 
appears to localise predominantly to the IFM. This complexity can only be appreciated when 199 
viewing 3D reconstructions rather than 2D slices. Future studies could use our approach to 200 
visualise basement membrane remodelling and cell response to inflammation or injury in 201 
tendons and other soft tissues. However, there is an immediate need for robust workflows 202 
permitting relative 3D fluorescent quantification in whole-mount tissue imaging. Therefore, 203 
future studies should establish such procedures to truly appreciate disease-state/age-related 204 
changes to connective tissue dynamics.  205 
Our protocols also improve upon existing μ-CT modalities for visualising tendon 206 
structure, providing the ability to segment both fascicles and IFM from 3D reconstructions. 207 
Previous studies using contrast agents have presented procedures to segment and identify some 208 
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but not all fascicles, but tendon structure could not be fully resolved (21). However, sample 209 
drying using the HMDS protocol presented here provided adequate contrast for segmentation 210 
of both fascicles and IFM in both species and allowed quantification of IFM volume and 211 
thickness in equine SDFT. By modifying a reverse clarification procedure and combining with 212 
a chemical drying process, we present a method that allows cleared tendons to be imaged using 213 
contrast-enhanced μ-CT, facilitated by HMDS desiccation. This provides a rapid, cost-214 
effective, non-specialised approach for μ-CT scanning, providing excellent contrast of tendon 215 
structure in both large and small animal models. However, we were unable to measure IFM 216 
volume in the rat Achilles, as the smaller IFM thickness in this tendon meant that, during 217 
segmentation, we were unable to discern between IFM and noise created by HMDS drying. 218 
Despite this caveat, this is the first study to report such methods for IFM volumetric 219 
measurements using μ-CT, finding that IFM represents a small volume of tendon (5-6%). Using 220 
segments derived from equine SDFT, we have also shown that mean IFM thickness, as 221 
measured by μ-CT, was between 19-22 µm for both HMDS-dried and bimodally imaged 222 
samples. This is in agreement with a previous study that described IFM thickness in the equine 223 
SDFT as measuring between 10-25 µm depending tendon regions (39), although we could not 224 
distinguish between IFM surrounding fascicles and fascicle bundles. 225 
Another benefit to our bimodal workflow is the potential reduction in sample, and 226 
therefore animal, numbers required. Our approach nullifies the need for two distinct samples 227 
for two separate analysis techniques, providing the potential to reduce the number of animals 228 
used for scientific research, in line with the 3Rs principle (20). Our methodology can also be 229 
implemented into pre-existing equipment workflows for confocal microscopy and μ-CT, and 230 
can integrate open-source options in the absence of specialist software, such as Icy software 231 
for 3D whole-mount fluorescence visualisation and ImageJ/BoneJ for tendon morphometric 232 
analyses (44,45). Given we have only utilised one clarification method, future studies could 233 
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investigate the effects of other clearing agents on tendon clarification, however other studies 234 
have compared a range of clearing solutions reporting no or limited effects on clearing of 235 
skeletally mature tendons (12,15). As clearing agents can have a tissue-specific effect, there is 236 
a greater need for understanding how clarification agents impact tendon ultrastructure, with 237 
previous studies demonstrating the destructive effects of different clearing agents when 238 
imaging GFP-labelled intestine samples (46). Here, we have not directly determined whether 239 
tendon ultrastructure was affected, but no visual differences in tendon macroscopic structure 240 
were apparent pre/post-clearing and after reverse clarification. Our Visikol-based procedure 241 
also provides flexibility, with multiple stopping points throughout the protocol for both short 242 
and long-term storage without deterioration prior to clearing. 243 
To enhance our methodology, 3D image registration of confocal and μ-CT images 244 
could be used for localisation of cellular and structural features of soft tissues such as tendon, 245 
whilst also enabling the identification of alterations in tissue sub-structure, such as basement 246 
membranes, with ageing and injury models. By combining imaging modalities, our method 247 
could visualise and analyse spatiotemporal differences in 3D, and would allow identification 248 
of injury-induced changes remote from injury site, especially for large animal tissues (47). 249 
These approaches have already been attempted in renal and cardiac injuries in adult mice, 250 
demonstrating that 3D approaches can inform regional differences in tissue repair (48,49). 251 
Hence, our proposed protocol could be scaled down for smaller samples, such as mouse 252 
Achilles tendon, to investigate regional differences in cell:ECM interactions in murine models 253 
of tendon injury using 3D whole-mount preparation. Furthermore, antibody detection and 254 
novel RNA in situ hybridisation techniques could be used in conjunction with 3D registration 255 
to establish 3D molecular maps of localised soft tissue markers as evidenced in the developing 256 
chick heart (50). Future studies could also pursue other potentially useful imaging modalities 257 
that could inform soft tissue structure-function relationships. For example, reversed clarified 258 
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tissues can be histologically prepared for quantitative polarised light microscopy (qPLM) to 259 
investigate the structural arrangement of collagen and other fibrous proteins (51–53). 260 
Therefore, 3D visualisation, image registration and subsequent analyses utilising bimodal 261 
imaging would greatly improve evaluation of a wide range of pre-clinical connective tissue 262 
disease models, as well as clinical samples. 263 
LIMITATIONS 264 
To the authors’ knowledge, whole-mount fluorescent imaging of tendon has only been 265 
described in mouse embryonic tendons using transgenic systems (54), which pose little 266 
difficulty for 3D imaging due to immature collagens/ECM, smaller size, and visualisation via 267 
GFP-labelling. However, no such method has been described for the clearing of fluorescently-268 
immunolabelled adult tendons from larger species where transgenic systems may not be 269 
financially or technically feasible. Despite this, our method does have some limitations. Firstly, 270 
antibody penetration appeared to differ in tendons from different species, with penetration 271 
throughout the depth of the rat Achilles (approximately 800 microns) but limited to 200 272 
microns in the equine SDFT, potentially due to lower surface area to volume ratio reducing 273 
ability for antibody diffusion. Similar limitations have been reported in osteochondral tissues 274 
labelled for large molecular weight ECM proteins, which also reported working depth as an 275 
issue for deep musculoskeletal tissue imaging (55). Despite this, our method significantly 276 
improves upon the 20 – 25 microns imaging depth achieved in the SDFT without clarification 277 
reported previously (56,57). We also note that scanning large regions of SDFT and whole rat 278 
Achilles was performed at low magnification due to working distance of the objective, such 279 
that it was not possible to fully resolve cellular structures. 280 
Limitations relating to μ-CT are also present in our method, mostly relating to scanning 281 
resolution. Segmentation of smaller structures and IFM remain a challenge despite the high 282 
resolution used to scan samples in this study. We found scans at a resolution of 1.6 microns 283 
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provided high enough resolution to identify tendon sub-structures in both species, although 284 
quantification was not possible in rat Achilles tendon. While we were able to visualise IFM in 285 
the rat Achilles, the segmentation process generated some noise that we could not distinguish 286 
from IFM due to the smaller IFM size in rat compared to equine tendon. Therefore, 287 
quantification was not performed, as specialised segmentation procedures will need to be 288 
developed to improve filtering of noise in these small samples. As for automatic segmentation 289 
of equine SDFT, a small amount of IFM appears to be lost as a result of smoothing and filtering 290 
of 2D slices. In our 3D analyses, IFM thickness is calculated as a single mean value, therefore 291 
overall distribution of IFM thickness could not be described. Finally, we observed a small 292 
amount of shrinkage in both rat and equine tissues, despite this, our measures of IFM thickness 293 
are consistent with previous reports, therefore our method provides a viable approach to 294 
visualise and measure tendon morphometry using μ-CT. 295 
To overcome these issues in either species, future scans could utilise higher-resolution 296 
or synchrotron-sourced x-ray tomography that offer greater imaging power. We also found that 297 
scanning without filters and using 180º projections provided the best acquisition of IFM in 298 
reconstructed images with reasonable scan time. Despite the aforementioned limitations, our 299 
approach permits sub-4-hour scans using benchtop μ-CT for downstream 3D volumetric 300 
analyses. Future studies could explore the benefits of various filters on scanning power when 301 
imaging tendon, whilst improvements to segmentation could be made with specialised 302 
segmentation routines such as adaptive local thresholding or machine-learning based 303 
segmentation (58). We also noted that, while HMDS desiccation eliminated external artefacts 304 
observed previously when scanning samples in air (59), we did observe some x-ray ring 305 
artefacts in the μ-CT scans. This is most likely a side effect of the drying process itself as well 306 
as not using a filter during scans, however these artefacts were easily removed by automated 307 
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reconstruction, ring smoothing and segmentation and as such do not pose any problems during 308 
3D visualisation or analysis.  309 
CONCLUSIONS AND PERSPECTIVES 310 
We report a novel bimodal imaging approach that utilises non-destructive, reversible 311 
clarification for 3D confocal microscopy of tendon which can be coupled with μ-CT procedures 312 
for analysis of tendon morphology. This methodology is a valuable addition to the imaging 313 
tools currently available to investigate both cellular and molecular biology of soft tissues, 314 
particularly in studies of comparative tendon biology to establish conserved structures and cell 315 
niche composition. By establishing a clarification protocol that enables study of tendon and 316 
other dense connective tissues, we address the lack of cost- and time-effective 3D fluorescent 317 
modalities for adult tissues. The introduction of chemical drying as a novel μ-CT preparation 318 
to enhance contrast of tendon structure provides the capacity to visualise and quantify tendon 319 
sub-structural features. Furthermore, both modalities can be performed independently of each 320 
other depending on experimental need and hypotheses. In conclusion, our bimodal imaging 321 
approach provides the capacity to visualise and analyse soft tissue structures, an advance which 322 
is likely to assist in pre-clinical or clinical investigation of connective tissue structure and 323 
pathologies. 324 
MATERIALS AND METHODS 325 
Sample preparation 326 
Achilles tendons were collected from female Wistar rats (age = 13 weeks, n = 2), 327 
euthanised for a related tendon injury study in which contralateral uninjured tendons were not 328 
required for analysis. Tendons were washed in Dulbecco’s phosphate buffered saline (DPBS), 329 
fixed in 4% paraformaldehyde for 24 hours at RT and stored in PBS with 0.05% sodium azide 330 
at 4ºC until processing. Forelimb SDFT were collected from female horses (n = 2, age = 7 and 331 
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23 years) euthanised at a commercial abattoir for reasons unrelated to tendon injury. Pieces 332 
(approximately 5 mm x 5 mm x 2 mm) were isolated from the mid-metacarpal region of the 333 
tendon, washed briefly in DPBS supplemented with 1% (v/v) antibiotic-antimycotic solution 334 
and fixed in 4% paraformaldehyde/10% neutral buffered formalin at RT for 24 h. Samples were 335 
stored in 70% ethanol at 4ºC until processing. 336 
Fluorescent immunolabelling and clarifying procedures 337 
Prior to whole-mount preparations, serial sections of equine SDFT and rat Achilles 338 
were fluorescently labelled with LAMA4 to validate expression in 2D and optimise antibody 339 
concentrations (see Supplementary Methods). For preparation of immunolabelled samples, 340 
equine SDFT segments and whole rat Achilles were processed according to VisikolTM 341 
guidelines. All steps were performed with orbital agitation at 60 RPM. SDFT segments were 342 
washed twice for 12 h with tris buffered saline (TBS) at RT, and permeabilised sequentially in 343 
50% (v/v) methanol:TBS, 80% (v/v) methanol:dH2O, and 100% methanol for 2 h at 4ºC. 344 
Samples were washed sequentially for 40 minutes at 4 ºC with 20% (v/v) dimethyl sulphoxide 345 
(DMSO):methanol, 80% (v/v) methanol:dH2O, 50% (v/v) methanol:TBS, TBS, and TBS 346 
supplemented with 0.2% (v/v) Triton X-100 (0.2% TBS-TX100). 347 
For rat Achilles tendons, permeabilisation was performed as described for equine 348 
SDFT, with the exception that DPBS was substituted for TBS in all steps. Use of either saline 349 
solution does not impact labelling of tissue. 350 
Prior to blocking, samples were incubated with a pre-blocking penetration buffer 351 
containing 0.2% TBS-TX100, 0.3 M glycine, and 20% DMSO for 6 h at 37 ºC. Equine SDFT 352 
segments were blocked for 80 h at 37 ºC in 0.2% TBS-TX100 supplemented with 6% (v/v) 353 
goat and 6% (v/v) donkey serum and 10% (v/v) DMSO. For rat Achilles tendons, blocking was 354 
performed in 0.2% TBS-TX100 supplemented with 6% (v/v) goat serum and 10% (v/v) DMSO. 355 
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Primary antibody incubations for rabbit anti-LAMA4 (1:200; STJ93891, St. John’s 356 
Laboratories) for equine SDFT and 1:100 for rat Achilles tendons were performed at 37 ºC for 357 
80 h in respective antibody buffer containing TBS supplemented with TWEEN20 (0.2% v/v; 358 
TBS-TWEEN20), 3% (v/v) goat serum, 3% (v/v) donkey serum, and 5% (v/v) DMSO. For rat 359 
Achilles tendon antibody incubations, donkey serum was omitted. 360 
Samples were washed three times for 2 h in wash buffer containing TBS-TWEEN20. 361 
Secondary antibody incubation was performed with goat anti-rabbit Alexa Fluor® 594 362 
(A11037, Fisher Scientific) diluted at 1:250 for equine SDFT and 1:500 for rat Achilles tendon 363 
in antibody buffer for 36 h for equine SDFT and 72 h for rat Achilles tendon at 37 ºC. Samples 364 
were washed five times for at least five minutes with wash buffer, before an overnight wash in 365 
wash buffer supplemented with 4',6-diamidino-2-phenylindole dihydrochloride (DAPI; 366 
1:2000) for cell nuclei counterstaining. Samples were dehydrated as described above with 367 
increasing concentrations of methanol. Two-step tissue clarification was performed by 368 
immersing samples in Visikol HISTO-1 for 36 h for equine SDFT and 72 h for rat Achilles, 369 
followed by immersion in HISTO-2 for at least 36 h at RT. Samples were stored in HISTO-2 370 
at 4 °C prior to confocal imaging. 371 
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Confocal imaging 372 
Samples were immersed in HISTO-2 on a glass-bottom dish fitted with a silicone 373 
chamber for imaging. Serial optical sections (equine SDFT z-stack = 200 µm; rat Achilles 374 
tendon z-stack = 1000 - 1500 µm) were acquired using a Leica TCS SP8 laser scanning 375 
confocal microscope with a motorised stage. Images were acquired with a HC PL FLUOTAR 376 
10x/0.32 dry objective lens at a resolution of 1,024 x1,024 px, pinhole size set to 1 Airy unit, 377 
frame average set to 1, line average set to 8, and electronic zoom set to 0.75. Sequential scans 378 
of samples (rat Achilles: approx. 7mm x 2mm x 1.5mm; equine SDFT: approx. 1mm x 1mm x 379 
0.2mm) were captured using lasers emitting light at 405 (blue channel; DAPI) and 561 (red 380 
channel; Alexa Fluor 594) nm to detect fluorescent signal, with low laser power (< 10%), and 381 
scanning speed set to 600 Hz. 3D rendering, segmentation, and projections were performed 382 
and visualised using Leica LAS X software (version 3.5.5) within the 3D module. Figures were 383 
produced using Inkscape (version 0.92). 384 
Reverse clarification and chemical drying for X-ray micro-computed tomography 385 
Reverse clearing of tissues post confocal imaging were performed by sequential washes 386 
for a minimum of 3 h in 30%, 50%, 70%, 80%, 90%, 96%, and 100% (v/v) ethanol. Samples 387 
were immersed in HMDS solution (SIGMA: 52619) for 3-6 h and air-dried at room temperature 388 
overnight prior to X-ray micro-computed tomography. 389 
X-ray micro-computed tomography (μ-CT) 390 
HDMS-dried equine SDFT and rat Achilles samples were affixed to a brass holder 391 
using dental wax and scanned using a Skyscan 1172F (version 1.5, Skyscan, Kontich, Belgium) 392 
with X-ray source at 40 kV tube voltage and 250 µA tube current with 1815 ms exposure time 393 
and 1.6 µm voxel size. 180º scans were performed with no filter, frame averaging at 5, with a 394 
rotation step at 0.2º and random movement set to 20. Slice reconstruction was performed in 395 
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NRecon (version 1.7.1.0). Grey scale and false-colour volume renderings were produced using 396 
CTVox (version 3.3.0, Bruker, Belgium).  397 
3D analysis of tendon IFM 398 
3D analysis of equine SDFT pieces were performed using a cylindrical volume-of-399 
interest (VOI) of 1.75 mm x 1.75 mm x 2 mm on all samples to avoid regions damaged by 400 
gross dissection of tendon. To process tendon plugs for 3D analysis, reconstructed images were 401 
processed using CTAn (version 1.17.7.1). To analyse tendon structure, we adapted existing 402 
workflows for bone analysis in CTAn (Table 1), to measure the volume of scanned tendon 403 
(TV), IFM volume (IV), relative IFM volume to tendon volume (IV/TV), and IFM thickness 404 
(IFM.Th). For 3D colour mapping of IFM thickness, BV and Tb.th were adapted as measures 405 
of IFM volume and thickness. These measurements were then used for 3D reconstruction and 406 
colour coded in CTVox (version 3.3.0). Graphs were produced in GraphPad Prism (version 407 
8.0.0). 408 
LIST OF ABBREVIATIONS 409 
3D - Three-dimensional; μ-CT - x-ray micro-computed tomography; DAPI - 4',6-diamidino-410 
2-phenylindole dihydrochloride; dH2O - Deionised water; DMSO - Dimethyl sulfoxide; 411 
DPBS - Dulbecco’s phosphate-buffered saline; ECM - Extracellular matrix; HMDS – 412 
Hexamethyldisilazane; IFM - Interfascicular matrix; LAMA4 - Laminin Subunit Alpha-4; 413 
SDFT - Superficial digital flexor tendon; TBS - Tris-buffered saline; TBS-TWEEN20 - 414 
Tris-buffered saline supplemented with tween20; TBS-TX100 - Tris-buffered saline 415 
supplemented with triton-x100; VOI - Volume-of-interest. 416 
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TABLES 624 
Table 1. Description of 3D tendon morphometric parameters. 625 
 626 
  627 
Original 
parameter 
name for 
bone 
analysis 
Adapted 
tendon 
parameter 
name 
Description of adaptation Justification 
Unit of 
measurement 
Tissue 
volume 
(TV) 
Tendon 
volume 
(TV) 
Provides a total 3D volume 
measurement of scanned 
tendon (VOI). 
Can be 
interpreted 
identically to 
tissue 
volume. 
mm3 
Bone 
volume 
(BV) 
IFM 
volume 
(IV) 
Provides a total volume 
measurement of binarised IFM 
within the VOI. 
Can be 
interpreted 
identically to 
bone 
volume. 
mm3 
Percent 
bone 
volume 
(BV/TV) 
Percent 
IFM 
volume 
(IV/TV) 
Provides a proportion of the 
tendon volume occupied by 
IFM. 
Can be 
interpreted 
identically to 
percent bone 
volume. 
% 
Trabecular 
thickness 
(Tb.Th) 
IFM 
thickness 
(IFM.Th) 
Provides a measurement of 
IFM thickness within the VOI. 
Can be 
interpreted 
identically to 
trabecular 
thickness. 
mm 
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FIGURE LEGENDS 628 
Figure 1. Visual workflow of bimodal tendon imaging by confocal microscopy and x-ray 629 
micro-computed tomography. (A) Schematic workflow of bimodal imaging of tendon with 630 
representative images of rat tendon after key processes in the protocol. Each modality can be 631 
performed independently of the other. Scale bar = 2.5 mm. (B) Visual timeline of typical 632 
bimodal 3D imaging modalities for whole rat Achilles and equine SDFT segment. 633 
Preparation for our optimised whole-mount confocal imaging takes a minimum of 16 days, 634 
whilst μ-CT modalities can be performed in 3 days following reverse clarification. 635 
Figure 2. 3D visualisation of whole-mount LAMA4-immunolabelled rat Achilles tendon. 636 
3D reconstructions of a rat Achilles tendon showing nuclear (blue; a,d,h) and LAMA4 (red; 637 
b,e,i) labelling, and with each channel overlaid to create a composite image (c,f,j). Transverse 638 
(xz) views of the 3D reconstructions (d-f) and tendon core with LAMA4-labelled IFM (h-j; 639 
magnification of white box) demonstrate signal present throughout the depth of the tissue. 640 
Longitudinal views (a-c) show an extensive network of LAMA4 positive labelling on the 641 
tendon surface. 642 
Figure 3. 2D slices and maximum projection images of rat Achilles tendon core 643 
demonstrate information gained from 3D visualisation compared to 2D imaging. 2D 644 
slices (a-c) show sparse labelling for LAMA4 (red; b,c) within a highly cellular structure 645 
(nuclei labelled blue; a). Maximum intensity projections (d-f) of the same region shown in a-646 
c demonstrate the presence of a complex network of LAMA4 positivity within the tendon 647 
core (e,f). 648 
Figure 4. 3D visualisation of LAMA4-immunolabelled equine superficial digital flexor 649 
tendon. 3D reconstructions of an equine superficial digital flexor tendon showing 650 
longitudinal nuclear (blue; a-c) and LAMA4 (red; e-g) labelling, and with each channel 651 
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overlaid to create a composite image (i-k) rotated at x=-45º, 0º, +45º. Transverse (xz) views 652 
of 3D reconstructions of equine SDFT (d,h,l) demonstrate signal present throughout the depth 653 
of the tissue. Interfascicular matrix (IFM) and fascicles (F) are denoted longitudinally (b) and 654 
transversely (d). 655 
Figure 5. 3D visualisation of x-ray micro-computed tomography-scanned rat Achilles 656 
tendon. 3D reconstructions in grey scale (a, c) and false-colour renderings (relative densities) 657 
(b,d) of rat Achilles tendon surface and core demonstrate the contrast between IFM and 658 
tendon substance created using HMDS drying. Automated segmentation allows 3D 659 
visualisation of IFM (white) in whole rat Achilles tendon (e). 660 
Figure 6. 3D visualisation of x-ray micro-computed tomography scanned equine SDFT. 661 
3D reconstructions in grey scale (a) and false-colour renderings (b) of equine SDFT 662 
demonstrate the contrast between IFM (green) and tendon fascicles (blue) using HMDS 663 
drying. 664 
Figure 7. 3D analysis of x-ray micro-computed tomography-scanned equine superficial 665 
digital flexor tendon. 3D reconstructions of segmented tendon and IFM thickness heatmaps 666 
(a-b) of chemically dried (HMDS only) and reverse cleared (Reverse cleared + HMDS) 667 
tendon. 3D analyses (c) demonstrate that both conditions share similar percentage of IFM 668 
volume (IV/TV) and IFM thickness (IFM.Th) measurements. 669 
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